Copyright
©The Author(s) 2015.
World J Gastroenterol. Mar 28, 2015; 21(12): 3657-3662
Published online Mar 28, 2015. doi: 10.3748/wjg.v21.i12.3657
Published online Mar 28, 2015. doi: 10.3748/wjg.v21.i12.3657
Figure 2 Cumulative incidence of urine microprotein abnormalities after treatment with adefovir dipivoxil with or without lamivudine or entecavir in chronic hepatitis B patients.
Cumulative incidence of A: Urine β2-microglobulin abnormality; and B: Retinol-binding protein abnormality with long-term adefovir dipivoxil (ADV) or entecavir (ETV) treatment.
- Citation: Jia HY, Ding F, Chen JY, Lian JS, Zhang YM, Zeng LY, Xiang DR, Yu L, Hu JH, Yu GD, Cai H, Lu YF, Zheng L, Li LJ, Yang YD. Early kidney injury during long-term adefovir dipivoxil therapy for chronic hepatitis B. World J Gastroenterol 2015; 21(12): 3657-3662
- URL: https://www.wjgnet.com/1007-9327/full/v21/i12/3657.htm
- DOI: https://dx.doi.org/10.3748/wjg.v21.i12.3657